Protease inhibitors in oral carcinogenesis and chemoprevention.
Lippman
S M
SM
Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston 77030-4009, USA. slippman@mdanderson.org
Matrisian
L M
LM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008954:Models, Biological; D009062:Mouth Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000517:prevention & control*; D011480:Protease Inhibitors / Q000378:metabolism*; D014176:Protein Biosynthesis; D014358:Trypsin Inhibitor, Bowman-Birk Soybean / Q000378:metabolism*
D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D014358:Trypsin Inhibitor, Bowman-Birk Soybean; C050417:trypsin-chymotrypsin inhibitor A-II (peanut)